Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion

被引:0
作者
Gesine B. Jaissle
Peter Szurman
Nicolas Feltgen
Bernhard Spitzer
Amelie Pielen
Matus Rehak
Georg Spital
Heinrich Heimann
Carsten H. Meyer
机构
[1] University Eye Clinic Tuebingen,Department of Neurology and Bernstein Center for Computational Neuroscience
[2] Centre for Ophthalmology,Department of Ophthalmology
[3] University Eye Hospital Freiburg,St. Paul’s Eye Unit
[4] University Eye Hospital,Department of Ophthalmology
[5] University of Goettingen,undefined
[6] Charité University Hospital,undefined
[7] University Eye Hospital,undefined
[8] University of Leipzig,undefined
[9] St. Franziskus Hospital,undefined
[10] Royal Liverpool University Hospital,undefined
[11] University of Bonn,undefined
[12] University Eye Clinic,undefined
[13] Centre for Ophthalmology,undefined
[14] Eberhard-Karls University of Tuebingen,undefined
来源
Graefe's Archive for Clinical and Experimental Ophthalmology | 2011年 / 249卷
关键词
Macular edema; Bevacizumab; Branch retinal vein occlusion; Intravitreal therapy; Predictive factors; Prognostic facotrs for visual improvement;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:183 / 192
页数:9
相关论文
共 126 条
[1]  
Wroblewski J(1984)Argon laser photocoagulation for macular edema in branch vein occlusion Am J Ophthalmol 98 271-282
[2]  
Wells JA(2009)A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the standard care vs corticosteroid for retinal vein occlusion (SCORE) study report 6 Arch Ophthalmol 127 1115-1128
[3]  
Mandelcorn MS(2010)Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion Am J Ophthalmol 149 147-154
[4]  
Nrusimhadevara RK(2004)Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases Retina 24 348-355
[5]  
Mester U(2002)Vitrectomy with arteriovenous decompression and internal limiting membrane dissection in branch retinal vein occlusion Retina 22 740-746
[6]  
Dillinger P(1998)Laser-induced chorioretinal venous anastomosis for nonischemic central or branch retinal vein occlusion Arch Ophthalmol 116 43-52
[7]  
Fekrat S(2001)Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion Ophthalmology 108 2249-2257
[8]  
Goldberg MF(2008)Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion Eye 22 42-48
[9]  
Finkelstein D(2009)Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with -bevacizumab Investig Ophthalmol Vis Sci 50 1025-1032
[10]  
Weiss JN(2008)Intraocular pharmacokinetics of bevacizumab after a single intravitreal injection in humans Am J Ophthalmol 146 508-512